Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2012-06-26 16:09:01
Reporting Period:
Filing Date:
Accepted Time:
2012-06-26 16:09:01
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1429260 Coronado Biosciences Inc CNDO Pharmaceutical Preparations (2834) 205157386
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1046351 Md L Glenn Cooper C/o Coronado Biosciences, Inc.
15 New England Executive Park
Burlington MA 01803
See Remarks Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Acquisiton 2012-06-22 10,000 $5.30 40,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
  1. Represents the weighted average purchase price for the reported transactions. The range of prices for such transactions was $5.2916 to $5.306. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  2. Includes shares of common stock issued on November 15, 2011 pursuant to the automatic conversion of preferred stock held by the reporting person.